RESEARCHER PROFILE

Ovidiu Chioncel

← Back to Carol Davila University of Medicine and Pharmacy

O

Carol Davila University of Medicine and Pharmacy

Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsAcute Myocardial Infarction ResearchMechanical Circulatory Support DevicesHeart rate and cardiovascular health

Ovidiu Chioncel works in Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Acute Myocardial Infarction Research, Mechanical Circulatory Support Devices, Heart rate and cardiovascular health. Recorded institutional associations include Carol Davila University of Medicine and Pharmacy, Institutul de Urgenţă pentru Boli Cardiovasculare "Prof.Dr. C.C. Iliescu", Institutul Clinic Fundeni.

409Publications
75,817Citations
77H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.

    2021 · 19,442 citations

  2. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

    2019 · 7,163 citations

  3. 2023 ESC Guidelines for the management of acute coronary syndromes

    2023 · 5,204 citations

  4. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    2019 · 4,774 citations

  5. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

    2024 · 3,024 citations

  6. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    2023 · 2,413 citations

  7. 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

    2022 · 2,171 citations

  8. The Global Health and Economic Burden of Hospitalizations for Heart Failure

    2014 · 2,046 citations

  9. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

    2022 · 1,106 citations

  10. 2025 ESC/EACTS Guidelines for the management of valvular heart disease

    2025 · 1,072 citations

  11. European Society of Cardiology: Cardiovascular Disease Statistics 2019

    2019 · 1,017 citations

  12. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases

    2024 · 993 citations

  13. Epidemiology and One-Year Outcomes in Patients With Chronic Heart Failure and Preserved, Mid-Range and Reduced Ejection Fraction: An Analysis of The ESC Heart Failure Long-Term Registry

    2017 · 922 citations

  14. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

    2019 · 911 citations

  15. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

    2017 · 883 citations

  16. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    2024 · 872 citations

  17. Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

    2020 · 815 citations

  18. EUR Observational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

    2013 · 806 citations

  19. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions

    2016 · 798 citations

  20. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

    2017 · 754 citations

  21. Contemporary Management of Acute Right Ventricular Failure: A Statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology

    2016 · 720 citations

  22. Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

    2021 · 710 citations

  23. Are Hospitalized or Ambulatory Patients with Heart Failure Treated in Accordance with European Society of Cardiology Guidelines? Evidence from 12 440 Patients of the ESC Heart Failure Long-Term Registry

    2013 · 667 citations

  24. Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology

    2019 · 611 citations

  25. Clinical Phenotypes and Outcome of Patients Hospitalized for Acute Heart Failure: The ESC Heart Failure Long-Term Registry

    2017 · 580 citations

← Return to the university profile